Faeth Therapeutics Inc (FTH): Next-Year EPS Estimate 94.41%
As of 2026-06-22, Faeth Therapeutics Inc (FTH) has a next-year EPS growth estimate of 94.41%. Featured in our EPS revision report on 2026-06-22.
FTH was first flagged by our screen on 2026-06-16 with a next-year EPS growth estimate of 93.72%. Since detection, the estimate has risen to 94.41% — a net gain of 0.69 percentage points across 1 upward revision. Current-year growth is projected at -691.77%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 94.41%
- EPS growth this year
- -691.77%
- EPS next quarter (est)
- -$4.16
- Last price
- $20.97
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-22 | 94.41% | -691.77% | -$4.16 | $20.97 |
| 2026-06-21 | 93.72% | -691.77% | -$5.04 | $17.82 |
| 2026-06-18 | 93.72% | -691.77% | -$5.04 | $17.82 |
| 2026-06-17 | 93.72% | -691.77% | -$5.04 | $16.65 |
| 2026-06-16 | 93.72% | -691.77% | -$5.04 | $14.53 |
Reports Featuring FTH
Screen Performance
Aggregate stats across all 1803 tickers our top-EPS-revision screen has flagged over the past 82 days.
- Median return since detection
- +3.2%
- % of tickers in the green
- 57%
- Median return on winners
- +19.6%
- Large revisions captured
- 859
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Faeth Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-22, Faeth Therapeutics Inc (FTH) has a next-year EPS growth estimate of 94.41%, based on analyst consensus.
When was the latest EPS estimate revision for FTH?▾
The most recent revision occurred on 2026-06-22, when analysts adjusted the next-year EPS growth estimate from 93.72% to 94.41%.
What sector and industry does Faeth Therapeutics Inc belong to?▾
Faeth Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. FTH appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Faeth Therapeutics Inc (FTH) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports